We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Test Measures Three Levels of Estradiol

By HospiMedica staff writers
Posted on 12 Oct 2004
A new improved test for estradiol is a chemiluminescent microparticle immunoassay (CMIA) that provides an initial result in 29 minutes.

The test, designed for use on the Architect systems of Abbott Laboratories (Abbott Park, IL, USA), measures low, medium, and high concentration levels of estradiol. More...
The company notes that estradiol testing can be useful for a variety of conditions, including early or delayed puberty, and can also play an important role in the treatment of infertility. The Architect i2000 and i2000SR systems can process up to 200 immunoassay tests an hour without compromising test throughput or turnaround time.

"The Architect estradiol test was designed to be sensitive and specific, providing precise results across the entire assay range,” noted William Brown, Ph.D., vice president, diagnostic assays and systems development, Abbott Laboratories. "In addition, Architect estradiol has excellent correlation to the ‘gold standard' gas chromatography mass spectrometry (GC-MS) testing. This correlation supports the excellent functional sensitivity and accuracy of the assay.”

Estradiol levels vary, depending on the condition being treated. Levels are usually low in children and men, but in women the levels rise and fall during the normal menstrual cycle. Thus, a diagnostic test has to be able to provide precise results across a wide measurement range.


Related Links:
Abbott Labs

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Xenon Light Source
CLV-S400
External Defibrillator
HeartSave Y | YA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.